1.01
-0.08(-7.34%)
Currency In USD
| Previous Close | 1.09 |
| Open | 1.1 |
| Day High | 1.1 |
| Day Low | 0.99 |
| 52-Week High | 7.96 |
| 52-Week Low | 0.67 |
| Volume | 246,905 |
| Average Volume | 7.62M |
| Market Cap | 5.12M |
| PE | -0.23 |
| EPS | -4.47 |
| Moving Average 50 Days | 1.15 |
| Moving Average 200 Days | 2.4 |
| Change | -0.08 |
If you invested $1000 in Beyond Air, Inc. (XAIR) since IPO date, it would be worth $17.12 as of February 21, 2026 at a share price of $1.01. Whereas If you bought $1000 worth of Beyond Air, Inc. (XAIR) shares 5 years ago, it would be worth $7.53 as of February 21, 2026 at a share price of $1.01.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections
GlobeNewswire Inc.
Yesterday at 1:00 PM GMT
GARDEN CITY, N.Y., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve th
Beyond Cancer Abstract Featuring Phase 1 Data on Intratumoral Ultra-High Concentration Nitric Oxide (UNO) in Solid Tumor Metastases to be Presented at the AACR Annual Meeting 2026
GlobeNewswire Inc.
Feb 04, 2026 1:00 PM GMT
GARDEN CITY, N.Y., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., a clinical stage biotechnology company developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for solid tumors and subsidiary of Beyond Air, Inc. (NAS
Beyond Air Schedules Third Fiscal Quarter 2026 Financial Results Conference Call and Webcast
GlobeNewswire Inc.
Jan 26, 2026 9:05 PM GMT
GARDEN CITY, N.Y., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve th